A New Drug Could Slow Alzheimer’s Disease, Data Show
Published
Published
Glassdoor Biogen and Eisai just released the full phase 3 data of a new Alzheimer's drug, lecanemab. The medication slowed the rate..
By Deena Beasley SAN FRANCISCO (Reuters) -An experimental Alzheimer's disease drug from Eisai and Biogen (NASDAQ:BIIB) slowed..